Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain

NIH RePORTER · NIH · R01 · $79,881 · view on reporter.nih.gov ↗

Abstract

Supplement Project Abstract Statement It is included with the supplement research plan

Key facts

NIH application ID: 10452913
Project number: 3R01DE029202-01S1
Recipient: UNIVERSITY OF CALIFORNIA-IRVINE
Principal Investigator: ZHIGANG David LUO
Activity code: R01
Funding institute: NIH
Fiscal year: 2021
Award amount: $79,881
Award type: 3
Project period: 2021-09-01 → 2022-08-31